Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Workman

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Arthroscopy, Sports Medicine, and Rehabilitation|January 16, 2026
Increased Inferior Capsular Thickness on Magnetic Resonance Imaging Is Associated With Adhesive Capsulitis of the HipDeepak V Chona, Galvin J Loughran, James Yoon, et al.
International Forum of Allergy & Rhinology|August 12, 2020
Suction mitigation of airborne particulate generated during sinonasal drilling and cauteryAlan D Workman, Roy Xiao, Allen Feng, et al.
The Laryngoscope|February 26, 2022
Rhinoplasty Patients Do Not Have Higher Rates of Antidepressant, Anxiolytic, and ADHD Medication UseLillian W Dattilo, Alan D Workman, Roy Xiao, et al.
International Forum of Allergy & Rhinology|March 11, 2024
The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthmaVinay K Rathi, Zachary M Soler, Rodney J Schlosser, et al.
International Forum of Allergy & Rhinology|November 25, 2021
Private payer-negotiated prices for FDA-approved biologic treatments for allergic diseasesAnnette A Wang, Vinay K Rathi, Roy Xiao, et al.
International Forum of Allergy & Rhinology|May 18, 2023
Trends in price, spending, and utilization of omalizumab among Medicare beneficiariesLillian W Dattilo, Vinay K Rathi, Rodney J Schlosser, et al.
International Forum of Allergy & Rhinology|January 15, 2025
Olfactory Cleft Opacification Improves With Intranasal Steroid Treatment and Is Correlated With Objective and Patient-Reported Olfactory OutcomesAlan D Workman, David K Lerner, Vinay K Rathi, et al.
International Forum of Allergy & Rhinology|May 26, 2017
Relative susceptibility of airway organisms to antimicrobial effects of nitric oxideAlan D Workman, Ryan M Carey, Michael A Kohanski, et al.
International Forum of Allergy & Rhinology|July 3, 2023
Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022Vinay K Rathi, Nicholas W Sawicki, Rodney J Schlosser, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitisAngela L Nocera, Sarina K Mueller, Alan D Workman, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Arthroscopy, Sports Medicine, and Rehabilitation|January 16, 2026
Increased Inferior Capsular Thickness on Magnetic Resonance Imaging Is Associated With Adhesive Capsulitis of the HipDeepak V Chona, Galvin J Loughran, James Yoon, et al.
International Forum of Allergy & Rhinology|August 12, 2020
Suction mitigation of airborne particulate generated during sinonasal drilling and cauteryAlan D Workman, Roy Xiao, Allen Feng, et al.
The Laryngoscope|February 26, 2022
Rhinoplasty Patients Do Not Have Higher Rates of Antidepressant, Anxiolytic, and ADHD Medication UseLillian W Dattilo, Alan D Workman, Roy Xiao, et al.
International Forum of Allergy & Rhinology|March 11, 2024
The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthmaVinay K Rathi, Zachary M Soler, Rodney J Schlosser, et al.
International Forum of Allergy & Rhinology|November 25, 2021
Private payer-negotiated prices for FDA-approved biologic treatments for allergic diseasesAnnette A Wang, Vinay K Rathi, Roy Xiao, et al.
International Forum of Allergy & Rhinology|May 18, 2023
Trends in price, spending, and utilization of omalizumab among Medicare beneficiariesLillian W Dattilo, Vinay K Rathi, Rodney J Schlosser, et al.
International Forum of Allergy & Rhinology|January 15, 2025
Olfactory Cleft Opacification Improves With Intranasal Steroid Treatment and Is Correlated With Objective and Patient-Reported Olfactory OutcomesAlan D Workman, David K Lerner, Vinay K Rathi, et al.
International Forum of Allergy & Rhinology|May 26, 2017
Relative susceptibility of airway organisms to antimicrobial effects of nitric oxideAlan D Workman, Ryan M Carey, Michael A Kohanski, et al.
International Forum of Allergy & Rhinology|July 3, 2023
Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022Vinay K Rathi, Nicholas W Sawicki, Rodney J Schlosser, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitisAngela L Nocera, Sarina K Mueller, Alan D Workman, et al.
Pageof 13